Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Gilead Sciences and Merck presented Phase 2 results showing 94.2% viral suppression in HIV patients treated with islatravir and lenacapavir. Both weekly and daily treatments achieved comparable ...

The national HIV prevalence was 16.3% among adults aged 15 years and older, translating to an estimated 7.4 million adults ...

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

People with HIV can safely receive donated kidneys from deceased donors with the virus, according to a large study that comes ...

The District 7 hopeful's affable personality and big smile have a way of softening the blow of his sometimes controversial and inaccurate words. His written words land harder.

U-WIN’s privacy policy contains an introduction and seven clauses. It is available on the website and can be accessed without authentication. This section first evaluates the privacy policy against ...

Black Efforts Against the Threat of AIDS focused its message on the Latinx community on Oct. 15, which is National Latinx AIDS Awareness Day.